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Sunday, February 16, 2014 59aand can validate the surfaces discovered from simulations using only 2 frag-
ments. Combining all these molecular dynamics methodologies we are able
to gain insights into the most likely interactions between proteins, and on the
most likely method of aggregation, and the potential structures of protein
aggregates.
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Many proteins form ordered structural aggregates called amyloid fibrils,
which are associated with numerous neurodegenerative diseases. Insulin, a
largely a-helical protein, undergoes conformational changes under certain
stress conditions leading to amyloid fibrils. Fibrillation of insulin poses a
problem in its long-term storage, reducing its efficacy in treating type II dia-
betes. Oligomeric dissociation of insulin into its monomer is the key step for
the onset of fibrillation. In the present study, we have used a non-toxic nine
residue peptide, NK9 (NIVNVSLVK) constituting mostly with hydrophobic
residues, which interferes fibrillation of insulin. The time course of insulin
fibrillation at 62C using Thioflavin T fluorescence shows an increase in
the lag time from 120 min without peptide to 236 min with peptide. TEM
micrographs show branched insulin fibrils in its absence and less inter-fibril
association in its presence. FTIR study shows, loss of a-helical structure of
insulin upon incubation, but if the peptide is added, secondary structure is
almost fully maintained for 3 h, though lost partially at 4 h. Size exclusion
chromatography study confirms the resistance of the peptide towards the olig-
omeric dissociation of insulin into its monomer in the course of fibrillation.
Saturation transfer difference (STD) NMR was used to confirm the binding
epitope of NK9, where the hydrophobic residues give signal of resonance
transfer being in close contact with insulin. MD simulation in conjunction
with PCA analysis reveals how the binding of NK9 governs the interruption
of insulin fibrillation. An estimation of probable aggregation site of insulin
gives a clue for NK9 activity. The present study is considered to be helpful
for architecting new peptide based leads for efficient stopping of aggregation
of insulin.
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Kinetic studies of protein aggregation processes based on the nucleation-
polymerization (NP) mechanism and/or its variants are often formulated in
terms of the law of mass action. Although these works have greatly
enhanced our knowledge in the microscopic descriptions of fibril/aggregate
formation (e.g., fragmentation and other secondary pathways), they have to
inevitably deal with a huge number of filament species Fn (n=1 to 10^3 ~
10^4 or even more) as well as a number of kinetic parameters. Very often
some kinetic assumptions for the species with a wide distribution of sizes
and shapes would be needed in order to simplify the calculation. In contrast,
starting from a phase-transition perspective, one is able to provide thermo-
dynamic insight into the nucleation-controlled kinetic behavior. In this
work, we propose to apply the kinetic Ising model to investigate the thermo-
dynamics and kinetics of protein aggregation. At mean-field (MF) level, our
model can offer thermodynamic interpretation to the lag time; in particular,
it can explain the effect of temperature, concentration, and seeding on the
change of kinetic profiles. Using four real proteins as examples, we show
that the calculated fibril stability is consistent with experimental measure-
ments. In addition, their kinetics can be classified according to a generalized
scheme of the model. Our results suggest that protein aggregation could be
studied within the framework of the Ginzberg-Landau phase transition
theory.
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Maintaining protein solubility is fundamental to proteostasis, as the formation
of diverse aggregated species is associated with a variety of cytotoxic eventsand disorders, including Alzheimer’s and Parkinson’s diseases. Increasing ev-
idence indicates that protein aggregation can be widespread in living systems,
as many different proteins aggregate upon cellular stress. The origins of this
proteomic metastability, however, remain unclear, as do the reasons only
certain proteins aggregate in vivo. We have applied simple models of cotransla-
tional folding and protein supersaturation to quantify metastability at a prote-
ome scale. We find that many proteins can shift from cotranslational to
posttranslational folding because of translation kinetics, a source of metasta-
bility for nascent chains. Further, we show that the proteins most vulnerable
to aggregation are those whose cellular
concentrations are high relative to their
intrinsic solubilities. These supersaturated
proteins constitute a metastable sub-
proteome involved in forming pathological
assemblies in stress and ageing. We find
that such proteins are overrepresented in
the biochemical processes associated with
neurodegenerative disorders, helping to
rationalise their specific cellular pathol-
ogies. We anticipate that this type of anal-
ysis can provide a generally applicable
basis for tracking the instability of pro-
teomes in ageing, stress, and disease.322-Pos Board B77
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As part of the protein quality control centre of the cell, many molecular chap-
erones tightly regulate amyloid proteins and seem to play an important role
in neurodegeneration. However, the precise mechanism of this interplay and
how its modification leads to disease remains elusive. Particularly oligomeric
species of amyloid proteins have emerged as the most important mediators of
neurotoxicity in neurodegenerative diseases. These amyloid species are
exceedingly hard to characterize as they are transient, heterogeneous and
rare relative to the monomeric and fibrillar states. Single-molecule fluores-
cence spectroscopy allows us to specifically characterise the oligomeric
species and follow their structural development during fibril formation and
dissociation. We employed this technique to characterise the oligomers
evolving during the aggregation of a recombinant tau variant carrying the
D280K mutation associated with some forms of frontotemporal dementia.
Further, we studied the in vitro interaction of these oligomers with the chap-
erone Hsp70 which has previously been identified as a key regulator of tau
turnover in the cell. We found that Hsp70 controls the oligomerisation
and fibrillisation of tau interacting more strongly with oligomers of a
certain size and structure. Our results provide insights into the molecular
mechanism by which Hsp70 inhibits tau aggregation and targets oligomers
for degradation.
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In the tragic event of an injury, the body’s main mechanism to hinder blood loss
is to form a thrombus. This process primarily consists of the conversion of
fibrinogen to fibrin through an enzymatic reaction catalyzed by thrombin.
The fibrin network’s structure is dependent on the concentration of thrombin
present as well as on environmental conditions during network formation.
Here we present how thrombin concentration and flow conditions affect the for-
mation of fibrin in a controlled environment. Fibrin networks are grown in a
microfluidic device and their porosity is determined using conductance mea-
surements in the presence of macroions of various sizes. The porosity of fibrin
is relevant to its biological role influencing the outcome in the wound healing
process.
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Biological function relies on biochemical reactions that require spatial prox-
imity between biomolecules. We are investigating how DNA segregation and
